{"chatcmpl-95Fz5ygwhHbh6fS34y9rl6UCQzw7V": {"usage_dict": {"completion_tokens": 61, "prompt_tokens": 1073, "total_tokens": 1134}, "data_dict": {"PMID36841821": [{"drug name": "S62", "target": [{"direct target": "PELI1/EGFR", "drug-direct target interaction": "disruptor"}], "tested or effective group": null, "drug tested in following diseases": ["breast cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzB5d0oHjWiZz8uYJofalUBnFuB": {"usage_dict": {"completion_tokens": 99, "prompt_tokens": 1131, "total_tokens": 1230}, "data_dict": {"PMID36399643": [{"drug name": "temozolomide", "target": [], "tested or effective group": null, "drug tested in following diseases": ["GBM"], "ClinicalTrials.gov ID": null}, {"drug name": "regorafenib", "target": [{"direct target": "autophagosome-lysosome fusion", "drug-direct target interaction": "inhibitor"}], "tested or effective group": null, "drug tested in following diseases": ["GBM"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzLUxdFBE1KNul7adDXyaq1Ds0Q": {"usage_dict": {"completion_tokens": 70, "prompt_tokens": 1086, "total_tokens": 1156}, "data_dict": {"PMID36966152": [{"drug name": "fatostatin", "target": [{"direct target": "AKT/mTORC1/GPX4 signaling pathway", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["null"], "drug tested in following diseases": ["glioblastoma", "GBM"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzTMkaW3MDTzy0nvTisQfDIP9bc": {"usage_dict": {"completion_tokens": 78, "prompt_tokens": 1171, "total_tokens": 1249}, "data_dict": {"PMID37321064": [{"drug name": "MAM", "target": [{"direct target": "NQO1", "drug-direct target interaction": "activator"}], "tested or effective group": ["cisplatin-resistant A549", "AZD9291-resistant H1975"], "drug tested in following diseases": ["non-small cell lung cancer", "NSCLC"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzZlGTV1CFR13ye9QStxhproc0a": {"usage_dict": {"completion_tokens": 130, "prompt_tokens": 1111, "total_tokens": 1241}, "data_dict": {"PMID37147437": [{"drug name": "ganciclovir", "target": [{"direct target": "EZH2", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["HCMV-induced glioblastoma"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}, {"drug name": "temozolomide", "target": [{"direct target": "EZH2", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["HCMV-induced glioblastoma"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzgJuIqe3QuFuMCt1IUiVhDhIJH": {"usage_dict": {"completion_tokens": 61, "prompt_tokens": 1132, "total_tokens": 1193}, "data_dict": {"PMID37036151": [{"drug name": "Eltrombopag", "target": [{"direct target": "TFEB", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["null"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FzoMsZUJKmuGWz7UYmqDciEEa9Q": {"usage_dict": {"completion_tokens": 70, "prompt_tokens": 1023, "total_tokens": 1093}, "data_dict": {"PMID36574773": [{"drug name": null, "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["CD39+ CD8+ T cells"], "drug tested in following diseases": ["lung cancer", "non-small cell lung cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95FztNAJ0pDM48JNlWHmcYOJXcJkd": {"usage_dict": {"completion_tokens": 163, "prompt_tokens": 1129, "total_tokens": 1292}, "data_dict": {"PMID36240971": [{"drug name": "TAK-228", "target": [{"direct target": "TORC1/2", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["NFE2L2-mutated LUSC", "KEAP1-mutated LUSC", "KRAS/NFE2L2- or KEAP1-mutated NSCLC"], "drug tested in following diseases": ["NSCLC", "LUSC"], "ClinicalTrials.gov ID": null}, {"drug name": "CB-839", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["NRF2-activated LUSC"], "drug tested in following diseases": ["NSCLC", "LUSC"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G03gAtffws6dX8mXLVIpz0ShXLu": {"usage_dict": {"completion_tokens": 58, "prompt_tokens": 1070, "total_tokens": 1128}, "data_dict": {"PMID37507782": [{"drug name": "sertaconazole", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["lung cancer xenograft models"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G07a3mXMETVghoQMYcOXzRWYkgC": {"usage_dict": {"completion_tokens": 68, "prompt_tokens": 1036, "total_tokens": 1104}, "data_dict": {"PMID37451272": [{"drug name": "F3-targeting agent", "target": [{"direct target": "F3", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["SA-\u03b2Gal+ GBM cells"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0Bip0DcekzQFObIQXunilNWIEf": {"usage_dict": {"completion_tokens": 162, "prompt_tokens": 1099, "total_tokens": 1261}, "data_dict": {"PMID37066699": [{"drug name": "Aloe-emodin", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["GBM"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}, {"drug name": "AE@ZIF-8 NPs", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["GBM"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}, {"drug name": "AE-NPs", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["GBM"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0LI0FcejHjqSMrzJHWnY1jLwxQ": {"usage_dict": {"completion_tokens": 89, "prompt_tokens": 1327, "total_tokens": 1416}, "data_dict": {"PMID35849035": [{"drug name": "depatuxizumab mafodotin", "target": [{"direct target": "EGFR", "drug-direct target interaction": "antibody-drug conjugate"}], "tested or effective group": ["EGFR-amp GBM", "EGFRvIII-mutant", "MGMT unmethylated"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0U1PV2tUDBFPueAesWvfsQZqZ5": {"usage_dict": {"completion_tokens": 8, "prompt_tokens": 1003, "total_tokens": 1011}, "data_dict": {"PMID36707509": []}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0Wc7vcVsPnVWNFT1pvp6WdmDPY": {"usage_dict": {"completion_tokens": 142, "prompt_tokens": 1227, "total_tokens": 1369}, "data_dict": {"PMID36272139": [{"drug name": "EPIC-0412", "target": [{"direct target": "MGMT", "drug-direct target interaction": "inhibitor"}, {"direct target": "DNA damage repair pathway", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["GBM"], "drug tested in following diseases": ["Glioblastoma multiforme"], "ClinicalTrials.gov ID": null}, {"drug name": "Temozolomide", "target": [{"direct target": "MGMT", "drug-direct target interaction": "affected by resistance"}], "tested or effective group": ["GBM"], "drug tested in following diseases": ["Glioblastoma multiforme"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0k0UbL8wohny4ew0TYy6MdRwYA": {"usage_dict": {"completion_tokens": 125, "prompt_tokens": 1067, "total_tokens": 1192}, "data_dict": {"PMID36970205": [{"drug name": "trametinib", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["KRAS-mutant NSCLC"], "drug tested in following diseases": ["NSCLC"], "ClinicalTrials.gov ID": null}, {"drug name": "IACS-010759", "target": [{"direct target": "mitochondrial complex I", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["KRAS-mutant NSCLC"], "drug tested in following diseases": ["NSCLC"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0saYAaUrfCOhQu1c3gMTpadCVV": {"usage_dict": {"completion_tokens": 63, "prompt_tokens": 1173, "total_tokens": 1236}, "data_dict": {"PMID37770937": [{"drug name": "oxamate", "target": [{"direct target": "LDHA", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["glioblastoma mouse model"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G0yBRsUXtUh0wOtyWV2beDLD0vp": {"usage_dict": {"completion_tokens": 68, "prompt_tokens": 1070, "total_tokens": 1138}, "data_dict": {"PMID37407818": [{"drug name": null, "target": [{"direct target": "APOBEC3A", "drug-direct target interaction": "suppression"}], "tested or effective group": ["drug-tolerant cancer cells"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G13pzfdO8ktaDIFx0dl3d2QegvJ": {"usage_dict": {"completion_tokens": 118, "prompt_tokens": 1134, "total_tokens": 1252}, "data_dict": {"PMID37831007": [{"drug name": "sotorasib", "target": [{"direct target": "KRASG12C", "drug-direct target interaction": "inhibitor"}], "tested or effective group": null, "drug tested in following diseases": ["non-small cell lung cancer"], "ClinicalTrials.gov ID": null}, {"drug name": "MRTX1133", "target": [{"direct target": "KRASG12D", "drug-direct target interaction": "inhibitor"}], "tested or effective group": null, "drug tested in following diseases": ["PDAC"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1CcZnUCatTz96AkVksWq07y23k": {"usage_dict": {"completion_tokens": 8, "prompt_tokens": 1021, "total_tokens": 1029}, "data_dict": {"PMID37091185": []}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1DfT4sRewqhZcXRN4ZscVRigsZ": {"usage_dict": {"completion_tokens": 122, "prompt_tokens": 1069, "total_tokens": 1191}, "data_dict": {"PMID36650267": [{"drug name": "KU60019", "target": [{"direct target": "ATM", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["lung cancer cell lines"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": null}, {"drug name": "VP-16", "target": [{"direct target": "TOP2\u03b2", "drug-direct target interaction": "poison"}], "tested or effective group": ["lung cancer cell lines"], "drug tested in following diseases": ["lymphomas", "leukemias", "lung cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1N3tD4SxuuwkXFoSVIeSa9eXK2": {"usage_dict": {"completion_tokens": 72, "prompt_tokens": 1171, "total_tokens": 1243}, "data_dict": {"PMID36948246": [{"drug name": "D-1553", "target": [{"direct target": "KRAS G12C", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["KRAS G12C-mutated NSCLC"], "drug tested in following diseases": ["NSCLC"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1TOB2JLNoJjaduCTHbZff2vk02": {"usage_dict": {"completion_tokens": 69, "prompt_tokens": 1040, "total_tokens": 1109}, "data_dict": {"PMID37147285": [{"drug name": "Z839878730", "target": [{"direct target": "KK-LC-1", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["TNBC ALDH+ cells"], "drug tested in following diseases": ["triple negative breast cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1Xr9voBTiDoSV43m9L9NJt2xQy": {"usage_dict": {"completion_tokens": 8, "prompt_tokens": 1004, "total_tokens": 1012}, "data_dict": {"PMID37244935": []}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1ZkArkiCHcOUd9E8AySTypVce7": {"usage_dict": {"completion_tokens": 110, "prompt_tokens": 1081, "total_tokens": 1191}, "data_dict": {"PMID37269335": [{"drug name": "PF-07284892", "target": [{"direct target": "SHP2", "drug-direct target interaction": "allosteric inhibitor"}], "tested or effective group": ["ALK fusion-positive lung cancer", "BRAFV600E-mutant colorectal cancer", "KRASG12D-mutant ovarian cancer", "ROS1 fusion-positive pancreatic cancer"], "drug tested in following diseases": ["lung cancer", "colorectal cancer", "ovarian cancer", "pancreatic cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1g5yQ6OegprNN3b7yOXQfWFIkQ": {"usage_dict": {"completion_tokens": 79, "prompt_tokens": 1164, "total_tokens": 1243}, "data_dict": {"PMID36942434": [{"drug name": "osimertinib", "target": [{"direct target": null, "drug-direct target interaction": null}], "tested or effective group": ["patients with metastatic non-small cell lung cancer harbouring sensitising"], "drug tested in following diseases": ["non-small cell lung cancer", "adenocarcinoma of the lung"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1nxqKiYBGTSUDN9yMICj5PxE4x": {"usage_dict": {"completion_tokens": 79, "prompt_tokens": 1123, "total_tokens": 1202}, "data_dict": {"PMID37264081": [{"drug name": "RMC-6272", "target": [{"direct target": "mTORC1", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["ER+/HER2- breast cancer cell lines with PIK3CA or PTEN mutations"], "drug tested in following diseases": ["breast cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G1sPiyukPGLKf2nGbtxgoadxB3B": {"usage_dict": {"completion_tokens": 105, "prompt_tokens": 1264, "total_tokens": 1369}, "data_dict": {"PMID36521103": [{"drug name": "SurVaxM", "target": [{"direct target": "survivin", "drug-direct target interaction": "activator"}], "tested or effective group": ["nGBM"], "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": ["NCT02455557"]}, {"drug name": "temozolomide", "target": [], "tested or effective group": null, "drug tested in following diseases": ["glioblastoma"], "ClinicalTrials.gov ID": []}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G218yaknxBX2h9W3uVaUToVsJ9q": {"usage_dict": {"completion_tokens": 150, "prompt_tokens": 1075, "total_tokens": 1225}, "data_dict": {"PMID37816716": [{"drug name": "PKC inhibitors", "target": [{"direct target": "AURKB", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["KRAS-mutated lung cancers"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": null}, {"drug name": "MEK1/2 inhibitors", "target": [], "tested or effective group": ["KRAS-mutated lung cancers"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": null}, {"drug name": "KRASG12C inhibitors", "target": [], "tested or effective group": ["KRAS-mutated lung cancers"], "drug tested in following diseases": ["lung cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G2BykjOat7Iau0apHn633qMqvgp": {"usage_dict": {"completion_tokens": 67, "prompt_tokens": 1048, "total_tokens": 1115}, "data_dict": {"PMID37141396": [{"drug name": "pralsetinib", "target": [{"direct target": "RET", "drug-direct target interaction": "inhibitor"}], "tested or effective group": ["CCDC6-RET fusion"], "drug tested in following diseases": ["TNBC", "breast cancer"], "ClinicalTrials.gov ID": null}]}, "model_str": "gpt-4-0125-preview"}, "chatcmpl-95G2Je3uPROF0lq7ReFTc8xix4aYc": {"usage_dict": {"completion_tokens": 8, "prompt_tokens": 1047, "total_tokens": 1055}, "data_dict": {"PMID36821441": []}, "model_str": "gpt-4-0125-preview"}}